Genetic drugs

Articles Galleries Videos
  • diabetes tablets, Green signal to Sun Pharma from USFDA, green signal to sun pharma from usfda, Genetic drugs

    Green signal to Sun Pharma from USFDA 12 July 2013

    Sun Pharma can now sell its generic diabetic medication, Repaglinide tablets. The United States Food and Drug Administration (USFDA) offered the pharmaceutical company permission to market Repaglinide exclusively in the US for 180 days. The generic version of Repaglinide tablets...

    Keywords: generic tablets, diabetes medication, Green signal to Sun Pharma from USFDA, Repaglinide tablets

    Read More